PERTH, Australia, Feb. 15, 2022 /PRNewswire/ -- Advanced
Human Imaging Limited (ASX: "AHI")
(NASDAQ: "AHI") announced today that Nick Prosser has been appointed interim
Non-executive Chairman of Advanced Human Imaging. Additionally, Dr.
Katherine Iscoe, Ph.D., Co-Founder
and former CEO of Advanced Human Imaging, will be rejoining the
leadership team as Director and CEO. The announcements were
made as AHI Chairman and CEO, Vlado
Bosanac, is moving into a strategic role as Head of Strategy
and Revenue Growth, effective immediately.
Mr. Prosser has served on Advanced Human Imaging's Board of
Directors since November 2018. He has
also served on the Board of Directors for numerous ASX listed
companies. Mr. Prosser is a former Founder of Canberra Data
Centres, which was acquired by Infratil and Commonwealth
Superannuation Corporation for an enterprise value of $1.16 billion in 2016 and brings over a decade of
experience in technology expansion and monetization.
"I look forward to working with the Advanced Human Imaging team
as interim Chairman at a time when digital health solutions are an
important contributor to improving the health of individuals
worldwide," said Mr. Prosser. "AHI's solutions, BodyScan, DermaScan
and FaceScan, span across all aspects of the rapidly growing
digital health market. We look forward to growing and capturing a
larger global market share due to the innovation, solutions and
robust leadership of Advanced Human Imaging."
Dr. Katherine Iscoe co-founded Advanced Human
Imaging in 2014 and served as its CEO from April 2015 until October 2016. She is
an expert and thought leader on Type
1 Diabetes and glucose optimization through
continuous glucose monitoring systems (CGMS). Her work in Type 1
Diabetes spanned several years and includes publications in
multiple international peer-reviewed journals. Her biomedical
research has provided critical insight on the differences
between interstitial glucose and blood glucose levels, which result
in a measurement reading when using CGMS. Her combination of
academic and practical experience in medical sciences, health and
wellness provides a unique and strategic advantage for the future
of Advanced Human Imaging and mHealth.
"As a co-founder of Advanced Human Imaging, I'm pleased with the
company's growth since its inception in 2014," said Dr. Iscoe. "As
we look forward, Mr. Prosser and I see an opportunity to expand the
company's remote patient monitoring and digital health solutions.
We are focused on executing as we work closely with Vlado Bosanac on a strategy and revenue model
that delivers shareholder value."
The Company is working to finalize an executive services
agreement with Dr. Iscoe. The material terms of Dr. Iscoe's
employment will be released to the market as required by Listing
Rule 3.16.4 once agreed upon and executed. The agreement is
expected to be executed later this week.
Vlado Bosanac said, "I have
always been open and transparent in regard to my personal dispute
with the Australian Tax Office (ATO). I feel it is best I step
aside and continue to try and reach a resolution. I want to assure
all shareholders that I will remain focused on Advanced Human
Imaging, the company I love and co-founded. I will continue to work
with the AHI Board and management to drive the company's vision as
Head of Strategy and Revenue Growth. I also feel this transition
comes at a time when the Company requires this to be my focus and
best use of my skill set. I am very confident in Dr. Iscoe and
Mr. Prosser as experienced and innovative executives who know
the company and its goals well."
About Advanced Human Imaging:
AHI has developed and patented a proprietary dimensioning
technology that enables its users to check, track, and assess their
dimensions in conjunction with known health risk indicators using
only a smartphone both privately and accurately.
Our goal is to assist our partners by empowering their consumers
with this capability. This in return gives our partners the ability
to assess, assist, and communicate outcomes with their consumers
when navigating day to day life. Whether this is a personal journey
to better health, understanding the risk associated with their
physical condition, tracking the changes they are experiencing
through training, dieting, or under medical regimes, or simply
wanting to be correctly sized for a garment when shopping online.
The AHI technology delivers this seamlessly, privately, and
cost-effectively in under one minute.
AHI has developed this capability by leveraging the power of
Computer Vision, Machine Learning, and patented algorithms, to
process the images and assessments on secure, enterprise-level
infrastructure, delivering an end–to–end experience that is
unrivalled in the industry. AHI simplifies the collection of
measurements and removes the human error present in traditional
Forward Looking Statements
This press release contains certain forward-looking statements,
including those relating to the regarding the use of proceeds and
other statements that are predictive in nature. Forward-looking
statements are based on the Company's current expectations and
assumptions. The Private Securities Litigation Reform Act of 1995
provides a safe-harbor for forward-looking statements. These
statements may be identified by the use of forward-looking
expressions, including, but not limited to, 'expect,' 'anticipate,'
'intend,' 'plan,' 'believe,' 'estimate,' 'potential,' 'predict,'
'project,' 'should,' 'would' and similar expressions and the
negatives of those terms. Prospective investors are cautioned not
to place undue reliance on such forward-looking statements, which
speak only as of the date of this presentation. The Company
undertakes no obligation to publicly update any forward-looking
statement, whether as a result of new information, future events or
otherwise. Important factors that could cause actual results to
differ materially from those in the forward-looking statements are
set forth in the Company's filings with the Securities and Exchange
Commission, including its registration statement on Form F-1, as
amended from time to time, under the caption 'Risk Factors.'
For more information please
For more information contact:
View original content to download
SOURCE Advanced Human Imaging